Overview
The Blood and Marrow Transplantation (BMT) Program at Cincinnati Children's Hospital Medical Center is a national and international leader in innovative uses of blood and marrow transplantation.
Our Success
In the twenty year history of the Blood and Marrow Transplantation Program at Cincinnati Children's, over 1000 transplants have been performed, including the nation's first successful blood and marrow transplant performed as treatment for sickle cell anemia and for autoimmune lymphoproliferative syndrome. Research has led to the successful treatment of Fanconi anemia, as well as increased success with alternative donor transplants. The BMT program is a leader in transplantation for immunodeficiency and histiocytic disorders.
Collaboration
There is a strong partnership between the BMT Program and other programs at Cincinnati Children's such as those in the Cancer Center, Immunodeficiencies Program, and Histiocytosis Program. The growth of the BMT program continues with expansion within the Hematology / Oncology Division and with potential collaborations with the new Translational Research Trials Office that will foster new research for children.
With a multidisciplinary team, the BMT program also provides patients with excellence in nursing care, pharmacy support and psychosocial care and has been a strong advocate for families finding short- and long-term housing.
Our Expertise
- Unrelated Donor Transplants; commended by the National Marrow Donor Program (NMDP) for best performance in donor search nationally
- Cord Blood Transplants
- Reduced Intensity Conditioning Therapy, especially for non-malignant disorders
- CD34 selected (stem cell) transplants for selected conditions
- Specializing in the definitive treatment of rare genetic disorders
- Bone Marrow Failure Syndromes
- Fanconi anemia
- Schwachman-Diamond syndrome
- Congenital Porphyria
- Diamond Blackfan syndrome
- Congenital Sideroblastic Anemia and others
Immunodeficiency Disorders SCID Wiskott Aldrich syndrome IPEX XLP ALPS XHIM CGD Chediak Higashi syndrome and othersHistiocytic Disorders HLH (Hemophagocytic Lymphohistiocytosis) High risk Langerhans Cell Histiocytosis (LCH) secondary HLH (e.g. following solid organ transplantation)
